ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

STEMart Introduces API Impurity Identification Services for Medical Devices

By: Get News
STEMart has recently introduced API Impurity Identification services for global clients.

New York, USA - December 26, 2022 - STEMart, a U.S.-based provider of comprehensive services for all stages of medical device development, has recently introduced API Impurity Identification services for clients in the medical device, pharmaceutical product, and consumer product industries using a variety of techniques under standard guidance.

Impurities are chemical species that differ from the chemical compositions of desired materials or compounds. Impurities that reveal during quality control or other processes may pose unexpected or adverse effects on the development of products, especially medical devices and pharmaceuticals. In order to minimize the occurrence of unexpected impurities in the manufacturing process, it is important to discover the origins of impurities.

Impurity identification is the process of using various analytical techniques to elucidate the identity of unknown substances in pharmaceuticals, medical devices, combination medicinal products or consumer products. Three types of impurities are commonly evaluated in impurity identification: organic impurities, inorganic impurities, and residual solvents. In fact, identifying and characterizing impurities is important for both product development and safety reasons, as they may be harmful to the health of users.

Various organizations, such as FDA and ICH, have established guidelines for the identification of impurities as well as acceptance criteria, identification thresholds, and identification procedures in medical devices or drug products. Specifically, USP general chapter "Impurities in Drug Substances and Drug Products" and USP "Organic Impurities in Drug Substances and Drug Products" stated regulations for pharmaceutical impurities, while USP and stated guidelines for elemental impurities.

STEMart provides impurity identification services for the medical device, pharmaceutical product, and consumer product industries using a variety of techniques under standard requirements. These Impurity Identification services include but are not limited to the isolation, analysis and identification of impurities. In addition, the scientific team of STEMart can develop and validate strategies to help with impurity monitoring for research customers.

STEMart's Analytical Techniques

1) Chromatography: HPLC, LC/MS, GC/MS, GC/FID, GC/TCD, GPC/SEC

2) Spectroscopy: ICP-MS, NMR, MS, PXRD, TF-XRD, UV-Vis, FTIR, Raman

3) Microscopy: SEM, TEM, AFM, STM, LSCM

4) Other: TGA, DSC, TOC, BET Surface Area/Pore Size Analyzer

STEMart offers comprehensive sterility testing for pyrogen-free products. With extensive expertise in microbiology and sterility testing, STEMart can provide full support for manufacturers in meeting regulatory goals and minimizing compliance risk.

If you have additional questions about API Impurity Identification services for medical devices or would like to know more about STEMart's medical device development service, please visit https://www.ste-mart.com.

About STEMart

STEMart is an industry-leading eCommerce platform incorporated with an extensive global footprint and a broad portfolio of more than 10,000 products. It aims to provide better lab materials, medical instruments and consumables, excellent technologies, and high-quality services to global customers in the fields of science, technology, and engineering, from the discovery stage upward to the manufacturing process. STEMart is dedicated to making research and biotech production simpler and safer in order to enhance access to better health worldwide.

Media Contact
Company Name: STEMart
Contact Person: Staci Horme
Email: Send Email
Phone: 1-516-665-1851
Country: United States
Website: https://www.ste-mart.com



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.